A Prospective, Single-center, Open-label, Pilot Study to Compare the Effectiveness and Safety of Diuretics Add-On Strategy in Chronic Heart Failure Patients (DIOS 1)
Condition: Congestive Heart FailureInterventions: Drug: furosemide/no spironolactone; Drug: metolazone/no spironolactone; Drug: furosemid/spironolactone; Drug: metolazone/spironolactoneSponsor: Yonsei UniversityWithdrawn - verified February 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Furosemide | Heart | Heart Failure | Metolazone | Research | Spironolactone | Study